CAS: 93413-62-8; O-Desmethylvenlafaxine

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报

上下游产品

4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenyl benzoate N,N-Didesmethyldesvenlafaxine formaldehyd 1-(2-amino-1-(4-methoxyphenyl)ethyl)cyclohexanol hydr°Chloride[2-(1-hydroxycyclohexyl)-2-(4-hydroxyphenyl)ethyl]dimethylammonium 3-carboxypropanoate monohydrate desvenlafaxine succinate (+/-)-1-[2-dimethylamino-1-(4-hydroxyphenyl)-ethyl]-cyclohexanol fumarate O-desmethyl-venlafaxine L-aspartate

合成工艺路线路线简述

  • 合成目标产物 O-Desmethylvenlafaxine 主要起始原料 Venlafaxine
  • 99300-78-4 = 93413-62-8
    反应条件:1.1 Reagents: Ethanethiol,Sodium Hydride Solvents: Dimethylformamide; 2 H,Rt1.2 Solvents: Dimethylformamide; Rt -> 40 °C; 20 Min,120 °C; 120 °C -> 150 °C; 2 H,150 °C; 20 Min,150 °C -> 5 °C1.3 Reagents: Acetic Acid,Hydrochloric Acid Solvents: Water; 35 °C; Ph 3,Rt1.4 Solvents: Toluene; 30 Min,Rt; 30 Min,Rt
    标题:Industrial Production Process Of O-Desmethylvenlafaxine From Venlafaxine Hydrochloride
    参考文献:China]

    99300-78-4 = 93413-62-8
    反应条件:1.1 Reagents: Potassium Carbonate Solvents: Polyethylene Glycol Monomethyl Ether; 30 Min,Rt1.2 Reagents: 2-Methyl-5-Tert-Butylthiophenol; 1 H,Rt -> 175 °C; 24 H,175 °C; 1 H,175 °C -> 80 °C1.3 Reagents: Water; 30 Min,80 °C1.4 Reagents: Hydrochloric Acid Solvents: Water; Ph 4 - 51.5 Reagents: Ammonia; Ph 9.5; 1 H,Rt
    标题:Process For Preparation Of 4-[2-(N-Substituted-Amino)-1-(1-Hydroxycyclohexyl-1-Yl)Ethyl]Phenols
    参考文献:World Intellectual Property Organization]

    1268269-56-2 = 93413-62-8
    反应条件:1.1 Reagents: Hydrogen Catalysts: Nickel Solvents: Methanol; Rt -> 50 °C; 2 H,50 Psi,50 °C1.2 Reagents: Ammonia Solvents: Water; Ph 9.5
    标题:Process For Preparing Desvenlafaxine,4-(2-Dimethylamino)-1-(1-Hydroxycyclohexyl)Phenol And Salts Thereof For Treatment Of Depressive And Vasomotor Menopause Disorders
    参考文献:Czech Republic]

    135308-76-8 = 93413-62-8
    反应条件:1.1 Solvents: Isopropanol,Water; 20 °C; 2 H,20 °C1.2 Reagents: Formic Acid Solvents: Water; 103 °C
    标题:Advances In Research At Synthesis Process Optimization And Quality Standard Improvement Of O-Desmethylvenlafaxine Succinate
    作者:Yang,Shiwei; Chen,Shiyun; Wang,Cheng; Zhang,Shibo; Li,Shuaifei; Et Al
    参考文献:Frontiers In Chemistry (Lausanne 日期:2022 卷标:10]

    93413-69-5 = 93413-62-8
    反应条件:1.1 Solvents: Polyethylene Glycol; 25 - 39 °C1.2 Reagents: 1,2-Ethanedithiol; 25 - 30 °C1.3 Reagents: Potassium Hydroxide; 30 Min,25 - 30 °C; 30 °C -> 190 °C; 24 H,140 - 190 °C; 140 °C -> 25 °C1.4 Solvents: Water; 25 - 30 °C1.5 Reagents: Hydrochloric Acid Solvents: Water; 25 - 30 °C1.6 Reagents: Ammonium Hydroxide Solvents: Water; 1 H,Ph 9 - 9.5,25 - 30 °C
    标题:An Improved Process For O-Demethylation Of Venlafaxine
    参考文献:India]

    93413-69-5 = 93413-62-8
    反应条件:1.1 Reagents: Chlorotrimethylsilane,Disodium Sulfide; 30 Min,Rt1.2 7 H,160 - 170 °C; 65 - 70 °C
    标题:Preparation Of O-Desmethylvenlafaxine By Demethylation Of Venlafaxine
    参考文献:World Intellectual Property Organization]

    93413-69-5 = 93413-62-8
    反应条件:1.1 Reagents: Potassium Hydroxide Solvents: Ethylene Glycol; 3 - 4 H,Rt -> 200 °C; 24 H,195 - 200 °C
    标题:Process For Preparation Of 1-[2-(Dimethylamino)-1-(4-Hydroxyphenyl) Ethyl]-Cyclohexanol And Salts Thereof
    参考文献:World Intellectual Property Organization]

    93413-69-5 = 93413-62-8
    反应条件:1.1 Reagents: Aluminum Chloride Solvents: Ethanethiol; 0.5 H,Rt1.2 Reagents: Phosphoric Acid Solvents: Water; Ph 3.51.3 Reagents: Ammonia Solvents: Water; Ph 9.5 - 10
    标题:Preparation Method Of Desvenlafaxine Succinate
    参考文献:China]

    93413-61-7 = 93413-62-8
    反应条件:1.1 Reagents: Ammonium Formate Catalysts: Palladium Solvents: Methanol; 2 H,60 °C1.2 Reagents: Ammonia Solvents: Water; Ph 9.5,Rt
    标题:Novel Oxalate Salts Of Desvenlafaxine Possessing Improved Aqueous Solubility And Bioavailability As Agents For Treatment Of Menopause-Related Depression And Vasomotor Disorders
    参考文献:Czech Republic]

    93413-61-7 = 93413-62-8
    反应条件:1.1 Reagents: Ammonium Formate Catalysts: Palladium Solvents: Methanol; 2 H,60 °C
    标题:Process For Preparing Desvenlafaxine And Salts Thereof
    参考文献:Czech Republic]

    93413-61-7 = 93413-62-8
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Tetrahydrofuran; 5 H,1 Mpa,Rt
    标题:Process For Synthesis Of Desvenlafaxine Succinate
    参考文献:China]

    93413-69-5 = 93413-62-8
    反应条件:1.1 Reagents: Lithium Tri-Sec-Butylborohydride Solvents: 1,2-Dimethoxyethane; 24 H,93 - 94 °C1.2 Reagents: Hydrochloric Acid Solvents: Water; Ph 3.5,10 - 15 °C1.3 Reagents: Sodium Hydroxide Solvents: Water; Ph 9.6
    标题:Novel Succinate Salt Of O-Desmethylvenlafaxine
    参考文献:World Intellectual Property Organization]

    93413-69-5 = 93413-62-8
    反应条件:1.1 Reagents: Triisobutylaluminum Solvents: Toluene; 20 - 30 °C; 20 H,Reflux; Reflux -> Rt1.2 Reagents: Water; < 30 °C1.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 5
    标题:Process For The Preparation Of Desvenlafaxine By Demethylation Of Venlafaxine Using Trialkylaluminum Or Dialkylaluminum Hydride Compounds
    参考文献:World Intellectual Property Organization]

    149289-29-2 = 93413-62-8
    反应条件:1.1 Reagents: Formic Acid Solvents: Acetic Acid,Water; 15 H,110 - 115 °C
    标题:Preparation Method Of O-Desmethylvenlafaxine
    参考文献:China]

    149289-29-2 = 93413-62-8
    反应条件:1.1 Reagents: Sodium Triacetoxyborohydride Solvents: Methanol; 4.66 H,Rt
    标题:Improved Process For Synthesizing Desvenlafaxine Free Base And Salts Or Solvates Thereof For Dosage Forms
    参考文献:World Intellectual Property Organization]

    93413-61-7 = 93413-62-8
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Ethanol; 6 H,30 °C
    标题:Synthesis Of Desmethylvenlafaxine
    作者:Xue,Na; Zhang,Kai; Hao,Xiaofei; Hao,Liuping; Wang,Le
    参考文献:Zhongguo Xiandai Yingyong Yaoxue 日期:2014 卷标:31(2) 页码:151-154]

    93413-61-7 = 93413-62-8
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Ethanol; 25 °C
    标题:Process For The Preparation Of O-Desmethyl Venlafaxine (Odv) From Phenylacetic Acid Derivatives,Dimethylamine,And Cyclohexanone
    参考文献:World Intellectual Property Organization]

    93413-61-7 = 93413-62-8
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Tetrahydrofuran; 12 H,1.5 Mpa,Rt
    标题:Synthesis Of O-Desmethylvenlafaxine Succinate
    作者:Wang,Peng; Cui,Xiangjuan; Liu,Weijia; Hai,Li
    参考文献:Zhongnan Yaoxue 日期:2012 卷标:10(3) 页码:175-177]

    149289-29-2 = 93413-62-8
    反应条件:1.1 Solvents: Isopropanol; 2 H,20 °C1.2 Reagents: Formic Acid Solvents: Water; 48 H,103 °C
    标题:Environmentally-Friendly Synthesis Method Of Desvenlafaxine And Its Succinic Acid Salt Using 4-Benzyloxyphenylacetonitrile
    参考文献:China
O-(4-Methoxybenzyl)Desvenlafaxine置于raney Nickel; Methanol Washed 氢气,氨体系中,用 四氢呋喃,甲醇,水 作为反应溶剂,50.0 °C,100.0 Kpa 条件下,反应 2.0H,以85%的收率获得产物o-去甲文拉法辛
参考文献: Method Of Preparing Desvenlafaxine And Its Salts[fr] Procédé De Préparation De Dévenlafaxine Et De Ses Sels
标题: Method Of Preparing Desvenlafaxine And Its Salts[fr] Procédé De Préparation De Dévenlafaxine Et De Ses Sels

海关参考信息

专利信息


专利号:US-12234200-B2
优先权日:2019-04-16
标 题:Synthetic methods of preparing esketamine
发明人:CHEN CHENG YI
权利人:JANSSEN PHARMACEUTICA NV
摘要:The present invention is directed to methods for the asymmetric synthesis of esketamine. The present invention is further directed to key intermediates in the asymmetric esketamine synthesis. In one embodiment, the invention is an asymmetric synthesis of esketamine comprising the conversion of (S)-2′-chloro-2-methoxy-3,4,5,6-5 tetrahydro-[1, 1′-biphenyl]-3-yl carbamate to (S)-2′-chloro-1-isocyanato-6-methoxy-1,2,3,4-tetrahydro-1,1′-biphenyl.

专利号:US-7605290-B2
优先权日:2006-07-26
标题 :Processes for the synthesis of O-desmethylvenlafaxine
发明人:NIDDAM-HILDESHEIM VALERIE; SHENKAR NATALIA; SHACHAN-TOV SHARONA
权利人:TEVA PHARMA
摘要:The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine.

专利号:US-2009069601-A1
优先权日:2006-07-26
标题:Processes for the synthesis of O-desmethylvenlafaxine
发明人:NIDDAM-HILDESHEIM VALERIE; NIDAM TAMAR; DOLITZKY BEN-ZION
权利人:NIDDAM-HILDESHEIM VALERIE; NIDAM TAMAR; DOLITZKY BEN-ZION
摘要:The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine.

专利号:US-2008221356-A1
优先权日:2006-07-26
标题:Processes for the synthesis of O-desmethylvenlafaxine
发明人:NIDDAM-HILDESHEIM VALERIE; NIDAM TAMAR; DOLITZKY BEN-ZION
权利人:NIDDAM-HILDESHEIM VALERIE; NIDAM TAMAR; DOLITZKY BEN-ZION
摘要:The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine.

专利号:US-2009137846-A1
优先权日:2006-07-26
标题 :Processes for the synthesis of O-Desmethylvenlafaxine
发明人:NIDDAM-HILDESHEIM VALERIE; NIDAM TAMAR; DOLITZKY BEN-ZION; FRENKEL GUSTAVO
权利人:NIDDAM-HILDESHEIM VALERIE; NIDAM TAMAR; DOLITZKY BEN-ZION; FRENKEL GUSTAVO
摘要:The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine.

专利号:WO-2008013995-A3
优先权日:2006-07-26
标题:Tridesmethylvenlafaxine and processes for the synthesis of o-desmethylvenlafaxine
发明人:NIDDAM-HILDESHEIM VALERIE; SHENKAR NATALIA; SHACHAN-TOV SHARONA
权利人:TEVA PHARMA; TEVA PHARMA; NIDDAM-HILDESHEIM VALERIE; SHENKAR NATALIA; SHACHAN-TOV SHARONA
摘要:The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine.
天津科创医药中间体技术生产力促进有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.scipharmacn.com
企业联系电话:022-60116533👤
📞天津科创医药中间体技术生产力促进有限公司 ⚠️参考联系方式
联系人:王经理
电话:022-60116533
手机:13207668525
传真:022-60979672
邮箱:saleskc@scipharmacn.com
通信地址: 天津市华苑产业园区(环外)海泰发展六道6号海泰绿色产业基地
邮编: 300118
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:天津市华苑产业园区(环外)海泰发展六道6号海泰绿色产业基地
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: McIntyre RS, Fayyad R, Mackell JA, Boucher M. Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder. Curr Med Res Opin. 2015 Dec
28:1-44. [Epub ahead of print] doi: 10.4088/PCC.14m01711. eCollection 2015.
3: McIntyre RS, Fayyad RS, Guico-Pabia CJ, Boucher M. A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/d. Prim Care Companion CNS Disord. 2015 Jun 4;17(3). doi: 10.4088/PCC.14m01741. eCollection 2015.

合成参考文献


参考文献:10.2165/11592070-000000000-00000
摘要:Watkins CC, Pieper AA, Treisman GJ. Safety considerations in drug treatment of depression in HIV-positive patients: an updated review. Drug Saf. 2011 Aug 01;34(8):623–39. doi: 10.2165/11592070-000000000-00000.
参考文献:10.1152/ajpgi.00044.2011
摘要:Dai F, Lei Y, Chen JDZ. Inhibitory effects of desvenlafaxine on gastric slow waves, antral contractions, and gastric accommodation mediated via the sympathetic mechanism in dogs. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2011 Oct;301(4):G707–12. doi: 10.1152/ajpgi.00044.2011.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知